Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
7Customers
3Debt Items
7Related Chains
Source-Backed Evidence Depth
Geron Corporation (GERN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
3Distinct source URLs
9High confidence
0.796Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Geron Corporation Suppliers
Ticker
Name
Confidence
Evidence
BIOPHARMA-CREDIT-INVESTMENTS-V-MASTER-LP
BIOPHARMA-CREDIT-INVESTMENTS-V-MASTER-LP
92%
On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
BIOPHARMA-CREDIT-PLC
BIOPHARMA-CREDIT-PLC
92%
On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
BPCR-LIMITED-PARTNERSHIP
BPCR-LIMITED-PARTNERSHIP
92%
On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
JANSSEN-BIOTECH-INC
JANSSEN-BIOTECH-INC
92%
Upon the effective date of termination of the license and collaboration agreement, or the Prior Collaboration Agreement, with Janssen Biotech, Inc., or Janssen, on September 28, 2018, we regained glo…
PHARMAKON-ADVISORS-LP
PHARMAKON-ADVISORS-LP
92%
On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
Reciprocal relationship from LCTX graph: Reciprocal relationship from GERN graph: Reciprocal relationship from LCTX graph: Reciprocal relationship from GERN graph: Reciprocal relationship from LCTX g…
ctual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on s…
ASTERIAS-BIOTHERAPEUTICS-INC
ASTERIAS-BIOTHERAPEUTICS-INC
62%
ctual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on s…
BIOPHARMA-CREDIT-PLC
BIOPHARMA-CREDIT-PLC
62%
rial impact on our financial statements. 2. REVENUE RECOGNITION Net Product Revenue To date, our only source of product revenue has been from the U.S. sales of RYTELO, which we began shipping to our …
BPCR-LIMITED
BPCR-LIMITED
62%
rial impact on our financial statements. 2. REVENUE RECOGNITION Net Product Revenue To date, our only source of product revenue has been from the U.S. sales of RYTELO, which we began shipping to our …
ROYALTY-PHARMA-DEVELOPMENT-FUNDING-LLC
ROYALTY-PHARMA-DEVELOPMENT-FUNDING-LLC
62%
y applicable make-whole and prepayment premiums); provided that upon an event of default relating to certain insolvency, liquidation, bankruptcy or similar events, all outstanding obligations will be…
USA-LLC
USA-LLC
62%
) Revenues: Product revenue, net $ 51,771 $ 39,436 $ 12,335 31 % Royalties 66 167 (101) (60) % Total revenues 51,837 39,603 12,234 31 % Costs and operating expenses: Cost of goods sold 1,692 1,206 48…
Geron Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
GERN-DEBT-9764
Warrants outstanding: 1619275
90%
xbrl warrant detail from xbrl 2025-12-31.
GERN-DEBT-9765
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2015-12-31.
GERN-DEBT
Debt stack $120.1M
90%
Market cache reports total debt of $120.1M.
Geron Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Geron Corporation.
Geron Corporation Ownership
Holder
Name
Confidence
Evidence
GERN-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 256 tracked holders.
